Scandinavian Real Heart AB — Investor Relations & Filings

Scandinavian Real Heart AB is a medical technology company developing a total artificial heart (TAH) for patients with life-threatening, end-stage heart failure. Its main product, the Realheart® TAH, is designed to completely replace a diseased heart, primarily serving as a transitional solution for patients awaiting a heart transplant. A key innovation of the device is its ability to mimic the natural heart's function by generating a pulsatile blood flow, which is intended to more closely replicate the body's physiological circulation. The company's objective is to save lives and improve the quality of life for individuals with advanced heart conditions. The device has received a Humanitarian Use Device (HUD) designation from the U.S. Food and Drug Administration (FDA).